A γ-caprolactone precursor-aroma compound and a preparation method and uses thereof are disclosed. The preparation method specifically includes: dissolving γ-caprolactone in a sufficient amount of a solvent, adding an alkali at −78° C. to 0° C., stirring the resulting mixture to allow a reaction for 20 min or more, adding 2-acetylpyridine, further stirring at −78° C. to 0° C. to allow a reaction for 30 min or more, quenching the reaction, and finally subjecting the resulting reaction system to post-treatment, separation, and purification to obtain the target lactone precursor-aroma compound. The precursor-aroma compound of the present disclosure has stable properties in a normal temperature environment, can uniformly release an aroma under heating, increase and enrich the types of lactone fragrances, broaden an application range of lactone fragrances and acylpyridines, and overcome the defects of lactone and acylpyridine themselves, such as high volatility, small threshold, strong smell, and easy loss during processing.

A γ-caprolactone precursor-aroma compound and a preparation method and uses thereof are disclosed. The preparation method specifically includes: dissolving γ-caprolactone in a sufficient amount of a solvent, adding an alkali at −78° C. to 0° C., stirring the resulting mixture to allow a reaction for 20 min or more, adding 2-acetylpyridine, further stirring at −78° C. to 0° C. to allow a reaction for 30 min or more, quenching the reaction, and finally subjecting the resulting reaction system to post-treatment, separation, and purification to obtain the target lactone precursor-aroma compound. The precursor-aroma compound of the present disclosure has stable properties in a normal temperature environment, can uniformly release an aroma under heating, increase and enrich the types of lactone fragrances, broaden an application range of lactone fragrances and acylpyridines, and overcome the defects of lactone and acylpyridine themselves, such as high volatility, small threshold, strong smell, and easy loss during processing.

An embodiment of the present disclosure provides a smoking article including a smoking material portion which is wrapped with a smoking material wrapper, a filter portion which has an upstream end combined with the smoking material portion and is wrapped with a filter wrapper, and a tipping paper which wraps around the filter portion and at least a portion of the smoking material portion so that the smoking material portion and the filter portion are combined, wherein a design printing layer, an overprint (OP) coating layer, and a sweetener coating layer are disposed on a surface of the tipping paper.

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a polymer matrix and one or more flavorants and/or active ingredients embedded in the polymer matrix. The polymer matrix can include a copolymer of ethylene and one or more vinyl monomers or zein. For example, the polymer can be ethylene-vinyl acetate copolymer and/or ethylene-vinyl alcohol copolymer. In some cases, the oral product can include tobacco and/or nicotine.

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a polymer matrix and one or more flavorants and/or active ingredients embedded in the polymer matrix. The polymer matrix can include a copolymer of ethylene and one or more vinyl monomers or zein. For example, the polymer can be ethylene-vinyl acetate copolymer and/or ethylene-vinyl alcohol copolymer. In some cases, the oral product can include tobacco and/or nicotine.

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a polymer matrix and one or more flavorants and/or active ingredients embedded in the polymer matrix. The polymer matrix can include a copolymer of ethylene and one or more vinyl monomers or zein. For example, the polymer can be ethylene-vinyl acetate copolymer and/or ethylene-vinyl alcohol copolymer. In some cases, the oral product can include tobacco and/or nicotine.

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a polymer matrix and one or more flavorants and/or active ingredients embedded in the polymer matrix. The polymer matrix can include a copolymer of ethylene and one or more vinyl monomers or zein. For example, the polymer can be ethylene-vinyl acetate copolymer and/or ethylene-vinyl alcohol copolymer. In some cases, the oral product can include tobacco and/or nicotine.

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a polymer matrix and one or more flavorants and/or active ingredients embedded in the polymer matrix. The polymer matrix can include a copolymer of ethylene and one or more vinyl monomers or zein. For example, the polymer can be ethylene-vinyl acetate copolymer and/or ethylene-vinyl alcohol copolymer. In some cases, the oral product can include tobacco and/or nicotine.

An oral product includes a body that is wholly receivable in an oral cavity. The body includes a polymer matrix and one or more flavorants and/or active ingredients embedded in the polymer matrix. The polymer matrix can include a copolymer of ethylene and one or more vinyl monomers or zein. For example, the polymer can be ethylene-vinyl acetate copolymer and/or ethylene-vinyl alcohol copolymer. In some cases, the oral product can include tobacco and/or nicotine.

The present invention describes a composition, such as a tobacco free or low tobacco nicotine containing composition, comprising: a. From about 0.2 wt % to about 2 wt % nicotine in free base form; b. a native cellulose material in an amount from about 35 wt % to about 60 wt %; c. water in an amount at least 35 wt %; d. one or more pH control salts in an amount from about 0.5 wt % to about 3 wt %; e. a release control agent comprising agar agar in an amount from about 0.1 wt % to about 2 wt % f. optional additional ingredients, preferably in an amount up to about 12 wt %. The composition may be provided in pouches for oral delivery to a user.